Styles, Lori <br/><br/>
Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study.  [electronic resource] 

 -  Journal of pediatric hematology/oncology  Jan 2015 
 - 1-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1536-3678 
<br/><br/><label>Standard No.: </label>10.1097/MPH.0000000000000291  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Anemia, Sickle Cell--blood<br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Male<br/>Models, Biological<br/>Piperazines--adverse effects<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Prasugrel Hydrochloride<br/>Purinergic P2Y Receptor Antagonists--pharmacokinetics<br/>Research Design<br/>Thiophenes--adverse effects